Metraipolis › archive › dc_2fa588eb0ca8

MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer — Europe PMC PMID:41375002

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41375002
DOI: 10.3390/cancers17233801
License (as archived): solo-consultazione
Archived: 2026-10-08T03:01:19.746Z
SHA-256 of the archived text: 24fb5b23917309e6e5910e78ed5f5cba558fcd8b4210f261df2ff310eee01a55
Stable URL of this page: https://metraipolis.com/documento/dc_2fa588eb0ca8

How to cite

MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer — Europe PMC PMID:41375002 — Europe PMC (en), https://europepmc.org/article/MED/41375002 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2fa588eb0ca8 (Metraipolis archive dc_2fa588eb0ca8, sha256 24fb5b23917309e6e5910e78ed5f5cba558fcd8b4210f261df2ff310eee01a55)

BibTeX

@misc{dc2fa588eb0ca8,
  title = {MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer — Europe PMC PMID:41375002},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41375002},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2fa588eb0ca8; sha256 24fb5b23917309e6e5910e78ed5f5cba558fcd8b4210f261df2ff310eee01a55},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41375002. Agents can read the archived copy with the MCP tool read_document.